Welcome to our dedicated page for Beyond SEC filings (Ticker: BYON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Beyond, Inc. (NYSE: BYON) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. In its filings, the company is identified under the Bed Bath & Beyond, Inc. name, with Beyond, Inc. noted as the former name or former address where applicable. These documents offer detailed information on the company’s financial condition, governance, compensation arrangements, and certain transactions.
Current reports on Form 8-K feature prominently in Beyond, Inc.’s filing history. Recent 8-K filings describe events such as the appointment of the Executive Chairman and principal executive officer as Chief Executive Officer, the termination of the Chief Operating Officer’s employment and related transition arrangements, and the adoption of the Bed Bath & Beyond, Inc. 2025 Employment Inducement Equity Incentive Plan. Other 8-Ks report on financial results for specific quarters, including the release of earnings for the three and nine months ended September 30, 2025.
Beyond, Inc. also uses Form 8-K to disclose investment and financing activities. Filings detail the company’s participation in loans issued by The Container Store, Inc. under a term loan credit agreement, including purchase prices for participation interests and the resulting rights to interest payments, repayment of principal, and related remedies. These disclosures help investors understand how the company allocates capital outside its core retail operations.
In addition to current reports, investors can consult Beyond, Inc.’s annual reports on Form 10-K and quarterly reports on Form 10-Q (not reproduced in full here) for comprehensive financial statements, segment information, risk factors, and management’s discussion and analysis. Proxy statements referenced in 8-K filings provide further detail on executive compensation and governance matters.
On this page, AI-powered tools can assist users by summarizing lengthy filings, highlighting key items such as leadership changes, equity incentive plans, and significant loan participations, and helping locate information on quarterly and annual results, governance decisions, and other material events relevant to BYON shareholders.
Bed Bath & Beyond, Inc. announced the adoption of its 2025 Employment Inducement Equity Incentive Plan. The plan reserves a maximum of 1,500,000 shares of common stock for equity-based awards.
Adopted without stockholder approval under NYSE Rule 303A.08, the plan permits non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. Grants may be made only as “employment inducement” awards and must be approved by a majority of Independent Directors or the Compensation Committee composed solely of Independent Directors.
The Vanguard Group filed Amendment No. 8 to Schedule 13G reporting beneficial ownership of 3,732,108 shares of Bed Bath & Beyond Inc. common stock, representing 6.5% of the class as of September 30, 2025.
Vanguard reports 0 shares with sole voting power and 342,440 with shared voting power. It has 3,368,994 shares with sole dispositive power and 363,114 with shared dispositive power. The filing identifies Vanguard as an investment adviser and states the securities were acquired and are held in the ordinary course, not to change or influence control.
Vanguard notes its clients, including registered investment companies and other managed accounts, may receive dividends or sale proceeds related to these securities, and no other single person’s interest exceeds five percent.
Bed Bath & Beyond, Inc. (BBBY) reported Q3 results for the period ended September 30, 2025. Net revenue was $257.2 million, down 17% year over year, as orders fell and average order value rose slightly. Gross margin improved to 25.3% from 21.2%, keeping gross profit roughly flat at $65.2 million. Operating loss narrowed to $(12.5) million from $(45.2) million, and net loss improved to $(4.5) million (basic and diluted EPS $(0.07)) from $(61.0) million.
Expenses declined across sales and marketing, technology, and G&A, reflecting tighter spending. Cash and cash equivalents were $167.4 million as of September 30, 2025. The company raised $101.7 million net by selling 12,432,021 shares under its at‑the‑market program, repurchased $4.9 million in Q3 and $6.2 million year to date, and had $63.7 million remaining on its repurchase authorization.
Strategic brand moves included acquiring buybuy BABY IP for $7.1 million, purchasing the Kirkland’s brand for $12.9 million, and recognizing a $5.0 million gain from selling Bed Bath & Beyond trademarks in Canada/UK. Subsequent event: a warrant dividend of one warrant per ten shares, exercisable at $15.50 and expiring on October 7, 2026, subject to early‑expiration conditions.
Bed Bath & Beyond, Inc. reported that it issued a press release with financial results for the three and nine months ended September 30, 2025. The company furnished the release as Exhibit 99.1 and posted an updated investor presentation in the Events & Presentation section of its investor relations site.
The information provided under Item 2.02 and in Exhibit 99.1 is furnished and not deemed filed under the Exchange Act.
BlackRock, Inc. filed Amendment No. 5 to Schedule 13G reporting beneficial ownership of 4,123,240 shares of Bed Bath & Beyond, Inc. common stock, representing 7.2% of the class as of 09/30/2025. BlackRock reported sole voting power over 4,025,167 shares and sole dispositive power over 4,123,240 shares, with no shared voting or dispositive power.
BlackRock certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing is signed by a Managing Director and includes a Power of Attorney exhibit.
Bed Bath & Beyond, Inc. updated its dealings with The Brand House Collective, Inc. on September 15, 2025. The company amended its existing term loan credit agreement to add new delayed-draw term loan commitments with an aggregate original principal amount of $20 million, which the company can convert into equity of The Brand House Collective, up to 75% of its outstanding common stock, under agreed conditions.
The company also amended its asset purchase agreement for the Kirkland’s brand, increasing the total purchase price from $5.233 million to $10 million for trademarks, domain names, and related brand assets, paid at closing on September 15, 2025. At the same time, Bed Bath & Beyond amended the existing trademark license so The Brand House Collective can continue using the Kirkland’s brand for its current stores, websites, and products, including an exclusive license for existing brick-and-mortar stores that lasts until the earlier of September 15, 2027 or the rebranding or closure of all such stores.
Bed Bath & Beyond, Inc. announced a warrant dividend to its common shareholders. Investors of record as of the close of business on October 2, 2025 will receive warrants to purchase additional common shares.
Each holder will receive one warrant for every ten shares of common stock, rounded down, with an exercise price of $15.50 per share. The warrants are expected to be distributed on or around October 7, 2025 and will expire on October 7, 2026. The company intends to apply to list the warrants on the New York Stock Exchange under the symbol BBBYW, allowing them to trade separately.
The company plans to file a Form 8-A registration statement and a prospectus supplement describing the warrant terms, and it has posted a detailed FAQ for investors. The communication clarifies that the warrant dividend itself is not an offer or sale of securities under the Securities Act.
Beyond, Inc. reported that, effective August 18, 2025, it changed its corporate name to Bed Bath & Beyond, Inc. through a certificate of amendment to its certificate of incorporation. The Board of Directors approved this change under Delaware law without a stockholder vote, and the amendment only updates the corporate name without altering stockholder rights.
The company’s common stock is expected to continue trading on the NYSE under the ticker BYON until the close of market on August 28, 2025. Trading is then expected to begin under the new ticker BBBY when markets open on August 29, 2025. On August 20, 2025, the Board also adopted Fifth Amended and Restated Bylaws, effective immediately, with detailed changes set out in exhibits to the report.